PUBLIC RADIO REPORT – AT THE CROSSROADS: AS OLD HEPATITIS C TREATMENT FADES OUT, NEW TREATMENTS STOKE HOPE
Rhode Island Public Radio recently hosted a series of informative radio segments on hepatitis C. We continue sharing this series with Part Three: As Old Hepatitis C Treatment Fades Out, New Treatments Stoke Hope. The series covers a range of topics relevant to both patients and providers, including infection statistics, populations at highest risk, the newest pharmaceuticals designed to combat hepatitis C, and barriers for patients attempting to access treatment.Click here to listen to Part Three of At the Crossroads.
In just a few weeks, another pharmaceutical company will likely win FDA approval for a new drug to cure hepatitis C. That makes three breakthrough medications hitting the market in less than a year. It’s big news for the estimated twenty thousand Rhode Islanders – and many more throughout New England – living with chronic hepatitis C. Because some have been waiting decades for a cure.
Next in our series “At The Crossroads: The Rise of Hepatitis C and the Fight to Stop it,” why one man waited so long for treatment.
If you are a person living with hepatitis C and have questions after reading this article or listening to the public radio broadcast, please call our helpline at 1-800-522-HEPC (4372).